If you would like to submit a blog post for consideration, please email email@example.com
This week we have an engaging case from Dr Tim Aung. A 56-year-old male with history of melanoma presented with a growing pigmented lesion left preauricular over 6-12 months.
Here are the clinical and dermoscopy images. What is your differential diagnosis, and how would you biopsy?
In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses melanoma guidelines and what to do when a difficult case falls outside the guidelines. Using real patient case examples, Giuseppe encourages physicians to assess melanomas on a case-by-case basis depending on the circumstances. Continue reading “[8 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [February 2019]”
This month, we share the latest publication from the Melanoma Guidelines Working Party, published in the latest Medical Journal of Australia. I will be presenting some thoughts and perspectives in coming months on each major recommendation. Continue reading “[3 min read] Prof David Wilkinson on melanoma guidelines: Dermoscopy”
In this skin cancer update, Professor Giuseppe Argenziano discusses treatments for difficult advanced melanoma cases. Looking at real patient examples, Giuseppe describes the options for treatment, including the factors physicians should consider when choosing therapies for their patients. Continue reading “[7 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [January 2019]”
[6 min watch] In this skin cancer update, Professor Giuseppe Argenziano discusses the best practice for patient follow-up, especially for patients with multiple moles. Continue reading “Skin Cancer Update with Prof Giuseppe Argenziano [December 2018]”
Did you know that obesity has been linked to increased mortality in several cancer types? The relation between obesity and survival outcomes in metastatic melanoma, however, have thus far remained unknown. So, a retrospective, multi-cohort study examined the association between body-mass index and progression-free survival or overall survival in patients with metastatic melanoma who received targeted therapy, immunotherapy, or chemotherapy.
Continue reading “What is the link between obesity and mortality in metastatic melanoma?”